Hanson McClain Advisors »

Rigel Pharmaceuticals shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Rigel Pharmaceuticals (RIGL) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Rigel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rigel Pharmaceuticals held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rigel Pharmaceuticals by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.5k 1.7k 1.48
2023-12-31 $2.5k 1.7k 1.45
2023-09-30 $1.5k 1.4k 1.08
2023-06-30 $1.8k 1.4k 1.29
2023-03-31 $1.8k 1.4k 1.32

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Us Treas Bd Etf (GOVT)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
Invesco Exch Traded Fd Tr Ii S&p 500 Revenue (RWL)
American Centy Etf Tr Us Eqt Etf (AVUS)
Ishares Tr Core S&p Ttl Stk (ITOT)
Apple (AAPL)

View all positions for Hanson McClain Advisors

Top funds holding Rigel Pharmaceuticals

Soleus Capital Management
Vanguard Group
Jacobs Levy Equity Management
Assenagon Asset Management
CM Management
GSA Capital Partners
Sphera Funds Management
Millennium Management
Charles Schwab Investment Management
Two Sigma Advisers
Thomas Stevens, CFA"
Connor, Clark & Lunn Investment Management
Bank of New York Mellon
Goldman Sachs Group
Squarepoint Ops

View all funds holding Rigel Pharmaceuticals